Navigation Links
Advantage Phencyclidine (PCP)Card

ProductsAdvantage Phencyclidine (PCP)Card
Company Inverness Medical Innovations
Item Advantage Phencyclidine (PCP)Card
Features 
  • Professional Use Only
  • In-Vitro Diagnostic and Forensic Use.
  • Description The ADC drugs of abuse tests are highly accurate in detecting the presence of drugs at the SAMHSA recommended cut-off as confirmed by GC/MS testing. The assay provides a preliminary test result. A more specific alternative method (such as GC/MS) must be used in order to obtain a confirmed result. Professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
    Info Inverness Medical Innovations
    Customer Service: 800-257-9525
    Web site: http://www.invernessmedical.com/

    Related medicine products :

    1. XL Advantage 3.5x @ 34cm working distance
    2. XL Advantage Prismatic
    3. XL Advantage 3.5x @ 46cm working distance
    4. XL Advantage 4.5x @ 34cm working distance
    5. XL Advantage 4.5x @ 42cm working distance
    6. XL Advantage 4.5x @ 46cm working distance
    7. XL Advantage 5.5x @ 34cm working distance
    8. XL Advantage 5.5x @ 42cm working distance
    9. XL Advantage 5.5x @ 46cm working distance
    10. MultiWash Advantage
    11. XL Advantage
    (Date:3/30/2017)... ... 30, 2017 , ... The Aresty Institute of Executive Education ... to address the increasingly complex educational needs of today's global executives. Corporate ... corporate finance and will increase their ability to confidently take action in ways ...
    (Date:3/30/2017)... ... 30, 2017 , ... Nutrition Education for the Public (NEP), ... join nonprofit Seafood Nutrition Partnership (SNP) in presenting “Eating Heart Healthy: Exploring Issues ... educators and students inform consumers about the health benefits of eating a seafood-rich ...
    (Date:3/29/2017)... ... , ... During the last week of March, Chad Kawa, MD of Revere ... the local community. , Colon cancer is the second leading cause of cancer ... it is small, confined and easier to treat. If you are 50 or older, ...
    (Date:3/29/2017)... , ... March 29, 2017 , ... ... women’s professional squash, announced it has enlisted New York City-based sports and entertainment ... will develop and procure sponsorship opportunities for the Professional Squash Association (PSA), which ...
    (Date:3/29/2017)... Baltimore, MD (PRWEB) , ... March 30, 2017 , ... ... , Charm City Run has announced that Mercy Medical Center will serve as the ... in the Mid-Atlantic region. On Sunday, June 25, 2017, thousands of women will walk ...
    Breaking Medicine News(10 mins):
    (Date:3/29/2017)... Research and Markets has announced the ... 2025" report to their offering. ... The global orthopedic navigation ... 2025. Increasing geriatric population prone to orthopedic diseases is a ... over the forecast period. Osteoarthritis and osteoporosis are most common ...
    (Date:3/29/2017)... , March 29, 2017  Experts in the ... monitoring devices like  Soberlink Systems  as a model ... paper, published in early 2017, concluded that remote ... in managing patient recovery." The findings ... of Addiction Medicine, detail a range of variables ...
    (Date:3/29/2017)... , March 29, 2017  Glenmark Pharmaceuticals, a ... GSP 301, an investigational fixed-dose combination of mometasone ... administered twice-daily as a nasal spray being studied ... results are from a recently completed Phase 3 ... 301 combination therapy versus mometasone, olopatadine or placebo. ...
    Breaking Medicine Technology: